Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.

Han LiYinan DingJiayan HuangYanyan ZhaoWei ChenQiusha TangYanli AnRong Chen Chun-Mei Hu

Published in: International journal of nanomedicine (2023)

In summary, excellent targeting ability, high antitubercular activity and biocompatibility endow ANG-Exo-RIF with potential for use in future translation-aimed research and provide hope for an effective CNS-TB treatment.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
stem cells
mesenchymal stem cells
angiotensin ii
human health
emergency department
cancer therapy
current status
drug delivery
hiv aids
climate change
cerebrospinal fluid
hepatitis c virus
adverse drug